Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synchrony
SYF
|
+$683M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$485M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$394M |
| 4 |
Apple
AAPL
|
+$378M |
| 5 |
Bausch Health
BHC
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$805M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$603M |
| 3 |
GE Aerospace
GE
|
+$548M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$426M |
| 5 |
Gilead Sciences
GILD
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 87.2% |
| 2 | Technology | 3.05% |
| 3 | Financials | 2.16% |
| 4 | Consumer Discretionary | 1.64% |
| 5 | Communication Services | 1.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
CNX Resources
CNX
$5.36B
| $2.96M | ﹤0.01% |
449,035
+213,792
| +91% | +$1.51M |
|
3277
Matsons
MATX
$6.71B
| $2.95M | ﹤0.01% |
69,301
+13,381
| +24% | +$624K |
|
3278
Amphenol
APH
$194B
| $2.95M | ﹤0.01% |
226,176
+17,700
| +8% | +$237K |
|
|
RGC
3279
CALL
DELISTED
Regal Entertainment Group
RGC
| $2.95M | ﹤0.01% |
156,500
-43,200
| -22% | -$821K |
|
3280
CALL
Graphic Packaging
GPK
$3.42B
| $2.95M | ﹤0.01% |
230,100
-24,600
| -10% | -$330K |
|
3281
CALL
iShares MSCI Spain ETF
EWP
$2.24B
| $2.95M | ﹤0.01% |
104,400
-46,700
| -31% | -$1.43M |
|
|
HNT
3282
DELISTED
HEALTH NET INC
HNT
| $2.95M | ﹤0.01% |
43,084
-86,303
| -67% | -$5.53M |
|
3283
Mettler-Toledo International
MTD
$28B
| $2.95M | ﹤0.01% |
8,695
+458
| +6% | +$147K |
|
|
SPIL
3284
DELISTED
Siliconware Precision Industries Co Ltd
SPIL
| $2.95M | ﹤0.01% |
380,366
+241,266
| +173% | +$1.68M |
|
3285
ProShares Ultra NASDAQ Biotechnology
BIB
$98.9M
| $2.95M | ﹤0.01% |
+41,225
| New | +$2.75M |
|
|
CJES
3286
PUT
DELISTED
C&J ENERGY SVCS LTD
CJES
| $2.95M | ﹤0.01% |
619,000
+75,300
| +14% | +$376K |
|
3287
First Trust China AlphaDEX Fund
FCA
$31.8M
| $2.94M | ﹤0.01% |
141,294
+47,496
| +51% | +$1.01M |
|
3288
CALL
Red Robin
RRGB
$176M
| $2.94M | ﹤0.01% |
47,600
-46,000
| -49% | -$3.23M |
|
|
STI
3289
PUT
DELISTED
SunTrust Banks, Inc.
STI
| $2.94M | ﹤0.01% |
68,600
-36,100
| -34% | -$1.52M |
|
3290
PUT
ProShares Ultra Russell2000
UWM
$248M
| $2.94M | ﹤0.01% |
148,400
+110,800
| +295% | +$2.3M |
|
3291
WisdomTree International Equity Fund
DWM
$691M
| $2.93M | ﹤0.01% |
62,915
-10,026
| -14% | -$479K |
|
3292
PUT
Pediatrix Medical
MD
$2.16B
| $2.93M | ﹤0.01% |
40,900
+34,900
| +582% | +$2.58M |
|
|
EGRX
3293
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $2.93M | ﹤0.01% |
33,053
+1,255
| +4% | +$99.1K |
|
3294
Invesco
IVZ
$14.5B
| $2.93M | ﹤0.01% |
87,393
+37,767
| +76% | +$1.24M |
|
|
ITCI
3295
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.93M | ﹤0.01% |
54,400
-23,500
| -30% | -$1.19M |
|
3296
Interactive Brokers
IBKR
$43.4B
| $2.92M | ﹤0.01% |
268,268
-80,472
| -23% | -$840K |
|
3297
ProShares UltraPro Russell2000
URTY
$325M
| $2.92M | ﹤0.01% |
78,840
+69,082
| +708% | +$2.76M |
|
3298
PUT
Ventas
VTR
$47.1B
| $2.92M | ﹤0.01% |
51,700
-45,200
| -47% | -$2.46M |
|
3299
CALL
Xcel Energy
XEL
$47.8B
| $2.92M | ﹤0.01% |
81,200
+8,700
| +12% | +$311K |
|
3300
Arrowhead Research
ARWR
$12B
| $2.91M | ﹤0.01% |
473,184
-114,029
| -19% | -$646K |
|
Similar funds
Jeff Yass's Q4 2015 Portfolio in Review
As of Q4 2015, Jeff Yass held 10,716 positions worth $216B, down 6.4% from $231B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Jeff Yass's Q4 2015 filing shows 1,138 new, 3,488 increased, 4,567 reduced and 1,373 closed positions. Its largest new stake was Alphabet (Google) Class A: 13,098,340 shares worth $510M. The largest sale was DuPont de Nemours, an estimated $805M.
By sector, the portfolio is most concentrated in Miscellaneous at 87% of assets, down from 87% a quarter earlier, followed by Technology and Financials.
- Jeff Yass's largest Q4 2015 buy was Alphabet (Google) Class A: 13,098,340 shares worth $510M.
- Jeff Yass added most to Synchrony in Q4 2015, an estimated $683M increase.
- Jeff Yass's biggest Q4 2015 reduction was DuPont de Nemours, cutting an estimated $805M.
- Jeff Yass fully exited Altera Corp in Q4 2015, selling an estimated $97.3M.
- Jeff Yass's ten largest holdings make up 21% of its $216B portfolio in Q4 2015.
- Jeff Yass opened 1,138 new positions and closed 1,373 in Q4 2015.
- Jeff Yass's portfolio value fell 6.4% quarter-over-quarter to $216B.
Based on Susquehanna International Group's 13F filing for Q4 2015, filed 16 Feb 2016.